ClariTrial | Search Clinical Trials

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,271 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 419

Recruiting

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Phase 2Locally Advanced Rectal Cancer (LARC)

ExperimentalControl

First Affiliated Hospital of Zhejiang University116 participants1 site · ChinaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer

Phase 2Esophagus CancerLung Cancer

Fosrolapitant and Palonosetron Hydrochloride for Injection combined with dexamethasone acetateFor injection, fosapirtan dimeglumine combined with palonosetron hydrochloride and dexamethasone acetate

Second Affiliated Hospital, School of Medicine, Zhejiang University120 participants1 site · ChinaCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Phase 2HER-2 Negative Breast Cancer

utidelone injectionBevacizumab

Henan Cancer Hospital79 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Ultralow Dose PET Imaging of 18F-FDG Uptake

Phase 2Healthy VolunteerCancer

18F-FDG

Akiva Mintz200 participants1 site · United StatesCompletes Jun 2030

Compare CT.gov Full analysis →

Recruiting

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Phase 2Central Nervous System NeoplasmCranial Nerve DisorderMetastatic Malignant Neoplasm in the Brain

FerumoxytolGadoliniumMagnetic Resonance Imaging

OHSU Knight Cancer Institute150 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study

Phase 2Esophageal Cancer

Durvalumab

Australasian Gastro-Intestinal Trials Group54 participants9 sites · Australia, New ZealandCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

Phase 2Colorectal CarcinomaColorectal NeoplasmsColorectal Tumor

encorafenib + cetuximab + FOLFIRI

Fondazione Policlinico Universitario Agostino Gemelli IRCCS25 participants3 sites · ItalyCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

INTERACT Stomach-II

Phase 2Peritoneal Metastases From Gastric Cancer

intraperitoneal chemotherapy

Erasmus Medical Center55 participants3 sites · NetherlandsCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer

Phase 3Cervical Cancer

Paraaortic prophylactic irradiation and pelvic definitive concurrent chemoradiationPelvic definitive concurrent chemoradiation

Zhejiang Cancer Hospital455 participants7 sites · ChinaCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

Phase 2Metastatic Colorectal Adenocarcinoma

FruquintinibTheraBionic P1

Barbara Ann Karmanos Cancer Institute102 participants9 sites · United StatesCompletes Apr 2028

Compare CT.gov Full analysis →

Recruiting

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

Phase 2Lung Non-Small Cell Carcinoma

Biopsy ProcedureBiospecimen CollectionComputed Tomography+4 more

Jonsson Comprehensive Cancer Center60 participants1 site · United StatesCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)

Phase 2Phase 3Metastatic Colorectal Cancer

HLX10HLX04、

Shanghai Henlius Biotech568 participants5 sites · China, JapanCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

Vorasidenib Maintenance for IDH Mutant Astrocytoma

Phase 3IDH-mutant Grade 2 or 3 Astrocytoma

VorasidenibVorasidenib Placebo

European Organisation for Research and Treatment of Cancer - EORTC468 participants33 sites · Austria, Belgium, CzechiaCompletes Apr 2035

Compare CT.gov Full analysis →

Recruiting

Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy

Phase 2Breast Cancer

Exemption from additional radiotherapy on the tumor bed after surgery

The First Affiliated Hospital with Nanjing Medical University150 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Electrochemotherapy of Gynecological Cancers

Phase 2Gynecological Cancers

Electrochemotherapy with bleomycin or cisplatin

Institute of Oncology Ljubljana30 participants1 site · SloveniaCompletes Dec 2025

Compare CT.gov Full analysis →

1–15 of 6,271

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,271 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 419

Recruiting

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Phase 2Locally Advanced Rectal Cancer (LARC)

ExperimentalControl

First Affiliated Hospital of Zhejiang University116 participants1 site · ChinaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Phase 2Esophagus CancerLung Cancer

Fosrolapitant and Palonosetron Hydrochloride for Injection combined with dexamethasone acetateFor injection, fosapirtan dimeglumine combined with palonosetron hydrochloride and dexamethasone acetate

Second Affiliated Hospital, School of Medicine, Zhejiang University120 participants1 site · ChinaCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Phase 2HER-2 Negative Breast Cancer

utidelone injectionBevacizumab

Henan Cancer Hospital79 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Ultralow Dose PET Imaging of 18F-FDG Uptake

Phase 2Healthy VolunteerCancer

18F-FDG

Akiva Mintz200 participants1 site · United StatesCompletes Jun 2030

Compare CT.gov Full analysis →

Recruiting

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Phase 2Central Nervous System NeoplasmCranial Nerve DisorderMetastatic Malignant Neoplasm in the Brain

FerumoxytolGadoliniumMagnetic Resonance Imaging

OHSU Knight Cancer Institute150 participants1 site · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study

Phase 2Esophageal Cancer

Durvalumab

Australasian Gastro-Intestinal Trials Group54 participants9 sites · Australia, New ZealandCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

Phase 2Colorectal CarcinomaColorectal NeoplasmsColorectal Tumor

encorafenib + cetuximab + FOLFIRI

Fondazione Policlinico Universitario Agostino Gemelli IRCCS25 participants3 sites · ItalyCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

INTERACT Stomach-II

Phase 2Peritoneal Metastases From Gastric Cancer

intraperitoneal chemotherapy

Erasmus Medical Center55 participants3 sites · NetherlandsCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer

Phase 3Cervical Cancer

Paraaortic prophylactic irradiation and pelvic definitive concurrent chemoradiationPelvic definitive concurrent chemoradiation

Zhejiang Cancer Hospital455 participants7 sites · ChinaCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

Phase 2Metastatic Colorectal Adenocarcinoma

FruquintinibTheraBionic P1

Barbara Ann Karmanos Cancer Institute102 participants9 sites · United StatesCompletes Apr 2028

Compare CT.gov Full analysis →

Recruiting

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

Phase 2Lung Non-Small Cell Carcinoma

Biopsy ProcedureBiospecimen CollectionComputed Tomography+4 more

Jonsson Comprehensive Cancer Center60 participants1 site · United StatesCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)

Phase 2Phase 3Metastatic Colorectal Cancer

HLX10HLX04、

Shanghai Henlius Biotech568 participants5 sites · China, JapanCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

Vorasidenib Maintenance for IDH Mutant Astrocytoma

Phase 3IDH-mutant Grade 2 or 3 Astrocytoma

VorasidenibVorasidenib Placebo

European Organisation for Research and Treatment of Cancer - EORTC468 participants33 sites · Austria, Belgium, CzechiaCompletes Apr 2035

Compare CT.gov Full analysis →

Recruiting

Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy

Phase 2Breast Cancer

Exemption from additional radiotherapy on the tumor bed after surgery

The First Affiliated Hospital with Nanjing Medical University150 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Electrochemotherapy of Gynecological Cancers

Phase 2Gynecological Cancers

Electrochemotherapy with bleomycin or cisplatin

Institute of Oncology Ljubljana30 participants1 site · SloveniaCompletes Dec 2025

Compare CT.gov Full analysis →

1–15 of 6,271